0.12 USD
▼-0.13-53.40%
盘后 0.11 -4.21%
2026-08-25
市值
$4.09M
市盈率
—
EPS
-0.38
股息率
—
52 周区间
0.08 – 1.24
成交量
27.45M
Beta
0.57
目标价
—
52W 低 0.0852W 高 1.24
价格走势
公司简介
OSR Health, Inc., a healthcare holding company, develops a portfolio of therapies and healthcare solutions in the United States, Europe, and Korea. The company develops immunotherapy products, including VXM01, an immuno-oncology candidate for glioblastoma completed phase 2 clinical trial, as well as preclinical stage products, such as VXM04 to treat mesothelin; VXM06 for the treatment of Wilms Tumor Protein (WT1); VXM08 for Carcinoembryonic antigen (CEA); and VXM10 for PD-L1. It is also developing design-augmented (DA) biologics comprising DRT-...